vktx stock Ignores 22% Weight Loss Breakthrough With No Plateau — Why Is Wall Street Cold Shouldering Viking?
Viking Therapeutics reported 22% weight loss versus placebo at week 33 with no plateau observed, yet VKTX stock reacted with muted trading. The stark gap...
